Table 4 Levels of microRNA 17-3P, CEA, and CA19.9 among group A and group B patients
miRNA | Group A (stage II + III ) (n = 25) | Group B (stage IV) (n = 25) | U | P |
|---|---|---|---|---|
Min.–max. | 1.74–29.86 | 2.71–32.45 | 1.0 | < 0.001* |
Mean ± SD | 7.48 ± 6.92 | 10.66 ± 7.37 | ||
Median | 5.28 | 8.69 | ||
CA19.9 | ||||
 Min.–max. | 0.25–63.0 | 0.62–700.0 | 93.0 | < 0.001* |
 Mean ± SD | 19.95 ± 17.25 | 58.86 ± 135.5 | ||
 Median | 12.0 | 32.0 | ||
CEA | ||||
 Min.–max. | 0.70–41.0 | 0.10–110.0 | 296.0 | 0.749 |
 Mean ± SD | 5.48 ± 8.09 | 11.78 ± 28.28 | ||
 Median | 2.90 | 2.70 | ||